Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years
Open Access
- 1 February 2015
- journal article
- Published by Elsevier in European Urology
- Vol. 67 (2) , 299-309
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- 11C-Choline PET/CT Scan in Patients With Prostate Cancer Treated With Intermittent ADTClinical Nuclear Medicine, 2013
- The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversyCritical Reviews in Oncology/Hematology, 2013
- Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation TherapyClinical Genitourinary Cancer, 2013
- Salvage Lymph Node Dissection with Adjuvant Radiotherapy for Nodal Recurrence of Prostate CancerJournal of Urology, 2012
- The Impact of Anatomical Radical Retropubic Prostatectomy on Cancer Control: The 30-Year AnniversaryJournal of Urology, 2012
- Predicting 15-Year Prostate Cancer Specific Mortality After Radical ProstatectomyJournal of Urology, 2011
- Long‐term overall survival and metastasis‐free survival for men with prostate‐specific antigen‐recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National DatabaseBJU International, 2010
- First Results of [11C]choline PET/CT-Guided Secondary Lymph Node Surgery in Patients with PSA Failure and Single Lymph Node Recurrence after Radical Retropubic ProstatectomyUrologia Internationalis, 2010
- [11C]Choline PET/CT for Targeted Salvage Lymph Node Dissection in Patients with Biochemical Recurrence after Primary Curative Therapy for Prostate CancerUrologia Internationalis, 2008
- The Natural History of Noncastrate Metastatic Prostate Cancer after Radical ProstatectomyEuropean Urology, 2007